
‘I’ve spent £20,000 on prostate cancer drug – but this new test could save NHS money’
Giles Turner, 64, has had high-risk prostate cancer since 2023 and has spent £20,000 on the drug abiraterone (Picture: Giles Turner) A new AI test can detect which men with high-risk prostate cancer could benefit from a life-extending drug. The technology …